Schedule 13G ownership disclosure

Alexza Pharmaceuticals Inc.

Security class unavailable · CUSIP: 015384100

Event date: 2014-08-29

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
637,764
Percent of class
3.6000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001318148-14-001512
Form type
SC 13G/A
Filer
Alexza Pharmaceuticals Inc.
CIK
CIK 1344413
Filed
Sep 10, 2014
Reporting period
Aug 29, 2014
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub